Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
2022 · EBioMedicine · 148 citations
https://doi.org/10.1016/j.ebiom.2022.103944
B
Belinda M. Dcosta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
1.2K
Citations
17
h-index
20
i10-index
Belinda M. Dcosta is an academic researcher from New York University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Animal Virus Infections Studies & SARS-CoV-2 detection and testing. The author has an h-index of 17, co-authored 20 publications.
ORCID: 0000-0001-8497-4942Papers by this author
worksAn ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
2020 · Cell Reports · 87 citations
https://doi.org/10.1016/j.celrep.2020.108528
High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals
2021 · Cell Reports · 25 citations
https://doi.org/10.1016/j.celrep.2021.110237
Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model
2023 · iScience · 11 citations
https://doi.org/10.1016/j.isci.2023.106092
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat